Phosphoinositide 3-kinase d inhibition promotes antitumor responses but antagonizes checkpoint inhibitors (2018)
Attributed to:
PI3K signalling in regulatory T cells.
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.120626
PubMed Identifier: 29875319
Publication URI: http://europepmc.org/abstract/MED/29875319
Type: Journal Article/Review
Parent Publication: JCI Insight
Issue: 11
ISSN: 2379-3708